These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22964925)
1. Impact of bacteremia in a cohort of patients with pneumococcal pneumonia. Palma I; Mosquera R; Demier C; Vay CA; Famiglietti A; Luna CM J Bras Pneumol; 2012; 38(4):422-30. PubMed ID: 22964925 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020 [TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile. Fica A; Bunster N; Aliaga F; Olivares F; Porte L; Braun S; Dabanch J; Hormázabal JC; Hernández A; Benavides MG Braz J Infect Dis; 2014; 18(2):115-23. PubMed ID: 24120831 [TBL] [Abstract][Full Text] [Related]
5. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J; Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264 [TBL] [Abstract][Full Text] [Related]
6. [Bacteremic pneumococcal pneumonia in 45 immunocompromised hospitalized adults]. Rioseco ML; Riquelme R Rev Med Chil; 2004 May; 132(5):588-94. PubMed ID: 15279145 [TBL] [Abstract][Full Text] [Related]
7. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia? Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331 [TBL] [Abstract][Full Text] [Related]
8. Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies. Vlachopoulos CV; Terentes-Printzios DG; Aznaouridis KA; Pietri PG; Stefanadis CI Eur J Prev Cardiol; 2015 Sep; 22(9):1185-99. PubMed ID: 25252595 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544 [TBL] [Abstract][Full Text] [Related]
10. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Ioachimescu OC; Ioachimescu AG; Iannini PB Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879 [TBL] [Abstract][Full Text] [Related]
13. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation. Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M; Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954 [TBL] [Abstract][Full Text] [Related]
14. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. Brandenburg JA; Marrie TJ; Coley CM; Singer DE; Obrosky DS; Kapoor WN; Fine MJ J Gen Intern Med; 2000 Sep; 15(9):638-46. PubMed ID: 11029678 [TBL] [Abstract][Full Text] [Related]
15. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Mykietiuk A; Carratalà J; Domínguez A; Manzur A; Fernández-Sabé N; Dorca J; Tubau F; Manresa F; Gudiol F Eur J Clin Microbiol Infect Dis; 2006 Jul; 25(7):457-62. PubMed ID: 16773389 [TBL] [Abstract][Full Text] [Related]
16. Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study. Ruiz LA; España PP; Gómez A; Bilbao A; Jaca C; Arámburu A; Capelastegui A; Restrepo MI; Zalacain R BMC Geriatr; 2017 Jun; 17(1):130. PubMed ID: 28633626 [TBL] [Abstract][Full Text] [Related]
17. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years. Jacups SP; Cheng A Vaccine; 2011 Jul; 29(33):5386-92. PubMed ID: 21651943 [TBL] [Abstract][Full Text] [Related]
18. [Bacteremic pneumococcal pneumonia in adults admitted to a general hospital. Experience in 60 cases]. Rioseco Z ML; Riquelme O R; Riquelme O M; Inzunza P C; Riquelme D J; Sanhueza R A Rev Med Chil; 2018 Jul; 146(7):839-845. PubMed ID: 30534882 [TBL] [Abstract][Full Text] [Related]
19. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia. Dwyer R; Hedlund J; Darenberg J; Henriques-Normark B; Naucler P; Runesdotter S; Kalin M Scand J Infect Dis; 2011 Jul; 43(6-7):448-55. PubMed ID: 21370939 [TBL] [Abstract][Full Text] [Related]
20. Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia. Wagenvoort GH; Sanders EA; de Melker HE; van der Ende A; Vlaminckx BJ; Knol MJ Vaccine; 2017 Mar; 35(14):1749-1757. PubMed ID: 28262334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]